Skip to main content
Prof. Dr. Pröbstel
Prof. Dr. Pröbstel
Rita Carubia, Universitätsspital Basel

News categories: Focus

Welcoming Anne-Katrin Pröbstel to ImmunoSensation

Our Cluster is delighted to welcome Prof. Dr. Anne-Katrin Pröbstel as a new member. Joining from the University of Basel, where she established herself as a leading expert in neuroimmunology and immune-microbiota interactions, Anne-Katrin Pröbstel brings her innovative research to our thriving immunological community in Bonn.

Research Focus: Bridging the Immune System and the Central Nervous System

The work of Anne-Katrin Pröbstel explores the interaction between the immune system and the central nervous system, particularly in the context of neuroinflammatory and neurodegenerative diseases. She is also interested in decoding the complex interactions between the microbiota and the immune system. Her research explores the mechanisms by which immune cells, such as B and T lymphocytes, contribute to neuroinflammation and neuronal damage. By using advanced techniques such as single-cell sequencing, proteomics, functional immunoassays, and gnotobiotic mouse models, she aims to uncover critical biomarkers and therapeutic targets to advance precision medicine in neurology.

Bonn - A Thriving Hub for Immunology

When asked why she chose to join the Cluster of Excellence ImmunoSensation2 in Bonn, Anne-Katrin Pröbstel highlighted the unique collaborative environment of the Cluster of Excellence.

"Bonn stands out for its interdisciplinary approach to immunology, where cutting-edge research is seamlessly integrated with clinical applications paving the way for translational of basic research to clinical practice. The opportunity to work with outstanding scientists and clinicians in such a supportive and innovative environment was a key factor in my decision," she explained.

The robust research network in Bonn, including scientists from the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), and the University Hospital Bonn, provides a great foundation for the Pröbstel group to pursue and continue their thriving research.

Looking Ahead: Perspectives and Goals

As she settles into her new role in Bonn, Anne-Katrin Pröbstel is excited about the possibilities to expand her research and collaborate on pioneering projects within ImmunoSensation2.

"I am eager to contribute to ImmunoSensation’s mission of understanding the immune system’s sensory functions and its role in health and disease. This community offers the perfect platform to translate our findings into meaningful clinical advances," she shared.

We warmly welcome Anne-Katrin Pröbstel to Bonn and look forward to the innovative scientific discoveries that her work will bring to the ImmunoSensation2 community.

 

Contact

Prof. Dr. Anne-Katrin Pröbstel

Center for Neurology & Clinic for Neuroimmunology German Center for Neurodegenerative Diseases

Venusberg-Campus 1, 53127 Bonn

mail: anne-katrin.proebstel@ukbonn.de

 

Related news

News Icon

News categories: Focus

Human Immunome Project Announces Scientific Partner Network

The Human Immunome Project (HIP) – a global NGO using artificial intelligence and big data to unlock the secrets of the human immune system in health and disease – today announced its Scientific Partner Network with nine founding institutional members on five continents. This landmark alliance brings together the world’s leading systems immunologists, clinical scientists, AI experts, and human biologists to establish common human study protocols and data standardization approaches that will be used to build the largest dataset of human immunological profiles.
View entry
Hartmann Wübben

News categories: Focus

An RNA key against viruses

Activating the body's antiviral defense system: A novel RIG-I ligand developed at the Medical Faculty of the University of Bonn and the University Hospital Bonn (UKB) helps the body to recognize and fight off certain viruses at an early stage. This molecular structure has potential for the prevention and treatment of viral infections. Based on the research results, there are now plans to develop and market an antiviral nasal spray to protect against viral respiratory infections.
View entry
members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program

News categories: Focus

Joining forces against future pandemics

Three days of scientific exchange, workshops, and new impulses: Until July 2, 2025, members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program are gathered at University Hospital Bonn (UKB) for a symposium to reflect on the current state of their research and discuss further steps. The joint program of the Cumming Global Centre for Pandemic Therapeutics at the University of Melbourne and of the University of Bonn aims to combat future pandemics with novel therapeutics.
View entry

Back to the news overview